RhythmAnalytics vs ClearRead CT
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
RhythmAnalytics by Biofourmis specializes in AI-powered interpretation of single-lead ECG data for cardiac arrhythmias, offering clinical decision support based on heart rhythm analysis. ClearRead CT by Riverain Technologies, on the other hand, focuses on enhancing the detection of pulmonary nodules and assessing coronary artery calcification within CT scans. While both are FDA-cleared AI tools applicable in cardiology, they address distinct diagnostic challenges using different data modalities (ECG vs. CT imaging).
Choose RhythmAnalytics if…
Choose RhythmAnalytics if your primary need is automated, AI-powered interpretation of cardiac arrhythmias from single-lead ECG data. This tool is ideal for healthcare professionals and integrators requiring real-time or near real-time clinical decision support for arrhythmia detection across various FDA-cleared ECG devices, enhancing efficiency in cardiac monitoring.
View RhythmAnalytics →Choose ClearRead CT if…
Choose ClearRead CT if your focus is on enhancing the accuracy and efficiency of cardiothoracic CT scan interpretation, particularly for pulmonary nodule detection and coronary artery calcification analysis. This AI suite is best suited for radiology departments and specialists seeking to improve diagnostic confidence, reduce reading times, and streamline workflows through advanced vessel suppression and automated nodule tracking.
View ClearRead CT →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | RhythmAnalytics | ClearRead CT |
|---|---|---|
| Pricing | Contact vendor | Contact for pricing |
| Deployment | Cloud-based API | On-premise (stand-alone server, virtual machine) and Cloud |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | RhythmAnalytics | ClearRead CT |
|---|---|---|
| Name | RhythmAnalytics | ClearRead CT |
| Company | Biofourmis Singapore Pte. | RIVERAIN TECHNOLOGIES |
| Description | FDA-cleared, AI-powered cloud-based software that provides automated interpretation of cardiac arrhythmias from single-lead ECG data, offering clinical decision support for healthcare professionals and integrators. | FDA-cleared AI suite by Riverain Technologies for cardiothoracic health, enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans. It improves diagnostic accuracy, reduces reading times, and streamlines radiology workflows through advanced AI and vessel suppression technology. |
| Categories | Cardiology AI, Clinical Decision Support & Reference | Cardiology AI, Oncology AI, Radiology & Imaging AI |
| Specialties | Cardiology, Emergency Medicine, Internal Medicine | Cardiology, Pulmonology, Radiology |
| Key Features | AI-based automated interpretation of cardiac arrhythmias, Detection of over 15 types of cardiac arrhythmias (including AFib, ventricular arrhythmias, ectopic beats), Beat-by-beat morphology computation, ECG signal processing and analysis, QRS and Ventricular Ectopic Beat detection, QRS feature extraction, interval measurement, heart rate measurement, and rhythm analysis, Cloud-based API for integration, Compatibility with FDA-cleared ECG devices (Holter, event recorders, wearable sensors) | Pulmonary Nodule Detection (solid, part-solid, ground glass), Patented Vessel Suppression (Clear Visual Intelligence), Nodule Characterization and Measurement (volume, diameter, location, type, depth), Automated Nodule Tracking and Comparison to Prior Exams, Coronary Artery Calcification (CAC) Scoring (ungated, non-contrast CTs), Reduced Reading Time (up to 36%), Improved Detection Accuracy (29% reduction in missed actionable nodules), Seamless PACS Integration / Vendor-neutral processing |
Videos
Demos, reviews, and walkthroughs featuring RhythmAnalytics and ClearRead CT.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
RhythmAnalytics is an AI-powered software focused on the automated interpretation of cardiac arrhythmias from single-lead ECG data, providing clinical decision support for healthcare professionals. ClearRead CT, on the other hand, is an AI suite designed for cardiothoracic health, specifically enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans.
RhythmAnalytics analyzes single-lead ECG data, compatible with FDA-cleared ECG devices such as Holter monitors, event recorders, and wearable sensors. ClearRead CT analyzes CT scan data to identify pulmonary nodules and assess coronary artery calcification.
RhythmAnalytics offers AI-based automated interpretation of over 15 types of cardiac arrhythmias, including beat-by-beat morphology computation and rhythm analysis. ClearRead CT utilizes AI for pulmonary nodule detection, characterization, automated tracking, patented vessel suppression, and coronary artery calcification scoring from ungated, non-contrast CTs.
RhythmAnalytics is designed for Cardiology, Emergency Medicine, and Internal Medicine. ClearRead CT supports Cardiology, Pulmonology, and Radiology specialties.
RhythmAnalytics integrates via a cloud-based API, allowing compatibility with various FDA-cleared ECG devices. ClearRead CT emphasizes seamless PACS integration and vendor-neutral processing to streamline radiology workflows.
ClearRead CT highlights specific benefits such as reduced reading time (up to 36%) and improved detection accuracy (29% reduction in missed actionable nodules). RhythmAnalytics focuses on providing automated interpretation and clinical decision support for cardiac arrhythmias without specifying similar quantifiable performance metrics in the provided information.